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Persistent staphylococcal infections are a major medical
problem, especially when they occur on implanted materials or
intravascular catheters. This review describes some of the recent-
ly discovered molecular mechanisms of Staphylococcus aureus
attachment to host proteins coating biomedical implants. These
interactions involve specific surface proteins, called bacterial
adhesins, that recognize specific domains of host proteins deposit-
ed on indwelling devices, such as fibronectin, fibrinogen, or fibrin.
Elucidation of molecular mechanisms of S aureus adhesion to the
different host proteins may lead to the development of specific
inhibitors blocking attachment of S aureus, which may decrease
the risk of bacterial colonization of indwelling devices (Infect
Control Hosp Epidemiol 1996;17:514-520).
INTRODUCTION
Despite the continuing development of potent antimi-
crobial agents, acute septic and chronic persistent infec-
tions due to Staphylococcus aureus1 and coagulase-negative
staphylococci (CNS) have increased in recent years.2-4
Major infections due to S aureus are either non–device-
related, such as surgical wound infections, or device-related.
The clinical significance of CNS in human infections was rec-
ognized only in the past 2 decades.2-4 This recognition was
delayed by the fact that these organisms were found to be
less virulent than S aureus in animal models of experimental
infection and frequently were considered to be contami-
nants of blood cultures. Coagulase-negative staphylococci
now are considered as the leading pathogens of indwelling
catheter and prosthetic device infections, thus contributing
to the majority of hospital-acquired bacteremias.2-4
Irrespective of their different virulence and persis-
tence characteristics, over the last decades, both S aureus
and CNS have accumulated multiple, unrelated resistance
determinants. Methicillin-resistant strains of S aureus or
Staphylococcus epidermidis, which frequently harbor sever-
al additional resistance determinants, represent a high risk
for severely ill patients. Control of such infections requires
expensive surveillance programs. 
ROLE OF IMPLANTED FOREIGN
BODIES ON SUSCEPTIBILITY TO
PERSISTENT STAPHYLOCOCCAL
INFECTION
The growing number of staphylococcal nosocomial
infections is due to the constant increase in transient or
permanent medical devices.5,6 Independently of their
physical and chemical composition, and whatever their
anatomical location, all artificial devices (eg, cere-
brospinal fluid shunts, intraocular lenses, pacemaker
wires and electrodes, prosthetic cardiac valves, vascular
grafts, prosthetic joints, intravascular catheters) exhibit
high susceptibility to microorganism infection. The pre-
dominant pathogens are S aureus1 and S epidermidis or
other CNS species.2,3 Both the presence of implanted
materials and the growing proportion of multiply antibiotic-
resistant strains of staphylococci complicate the therapy
of such infections, which are persistent and difficult to
cure without implant removal and replacement.7
DEVELOPMENT OF EXPERIMENTAL
MODELS OF FOREIGN BODY
INFECTIONS
The development of an animal model that could
reproduce some major features of clinically encountered
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foreign body infections was essential for studying various
aspects of bacterial colonization and the blunted host
response to a low microbial challenge. Another useful appli-
cation of animal models was to evaluate the most effective
antibiotic regimens for prophylaxis or therapy of implant-
associated infections. The tissue cage model that we have
used in the past 15 years is composed of polymeric multi-
perforated cylinders (called tissue cages) that are implant-
ed subcutaneously in guinea pigs8,9 or rats10,11 for sever-
al weeks. The perforations in tissue cages allow repeated
sampling of fluids for analysis of proteins, host cells, and
microbial organisms during infection. In addition, tissue
cages may be implanted with inserted polymethyl-
methacrylate (PMMA) coverslips, which are useful tools
for studying the reactive extracellular matrix deposited dur-
ing implantation and for evaluating its impact on microbial
adhesion and colonization. 
The tissue cage model has been used in two different
animals for two separate applications: in guinea pigs,
implanted tissue cages are very sensitive to a low bacterial
challenge and are most appropriate for virulence8,9 and
prophylactic studies12,13; in rats, implanted tissue cages
are infected in a more chronic mode (by S aureus only).
These animals are more tolerant to prolonged antibiotic
courses, thus allowing therapeutic trials to be extended for
periods of 1 to 3 weeks.10,11,13
PHAGOCYTIC DEFECTS
Polymorphonuclear neutrophils collected from tis-
sue cage fluid of guinea pigs were found to be markedly
defective in their content of granule-associated bactericidal
enzymes and in their oxidative burst-dependent bacterici-
dal activity against S aureus,9,14 compared to those of
blood9,14 or peritoneal15 neutrophils. These defects were
reproduced partly in vitro by exposure to artificial surfaces
in suspension and suggest mechanisms of frustrated
phagocytosis.14 Additional studies were performed of poly-
morphonuclear neutrophil functions in relationship with
phagocytosis of S aureus colonizing implants in order to
analyze surface phagocytosis of bacteria colonizing artifi-
cial surfaces. In vitro coating of polymer surfaces by native
plasma or matrix proteins markedly improved the phago-
cytic killing of surface-attached S aureus.16 These con-
trasting in vitro versus in vivo observations suggest that
chronically implanted materials may contain regions where
plasma and extracellular matrix proteins have been degrad-
ed locally by released proteolytic enzymes, which may
impair phagocytic recognition and killing of surface-
attached bacteria and lead to their improved survival. 
Partial restoration of locally deficient neutrophils in
tissue cage fluid and increased resistance to a bacterial chal-
lenge can be achieved not only by local transfusion of fresh
neutrophils14 but also by local injection of particulate
immunomodulators (ie, cell-wall components of S aureus)
that can increase the concentrations of local cytokines,8 in
particular, of tumor necrosis factor. A causal relationship was
found between the locally increased tissue cage fluid levels of
tumor necrosis factor, which is known to promote neutrophil
functions, and the prevention of foreign body infections.8
ROLE OF PLASMA AND
EXTRACELLULAR MATRIX PROTEINS
FOR PROMOTING STAPHYLOCOCCAL
ADHESION TO FOREIGN IMPLANT
SURFACES
Microbial adhesion is a key step for the colonization
of indwelling devices. On their surface, staphylococci, in
particular S aureus, express several specific receptors or
adhesins17-20 for interacting with a number of host pro-
teins such as fibrinogen,21-24 fibronectin,22,25-28 colla-
gen,29-32 vitronectin,33,34 laminin,22,35
thrombospondin,36 bone sialoprotein,37,38 elastin,39 and a
recently described extracellular matrix-binding protein
with broad specificity.40 Several in vitro studies have
demonstrated that these adhesins promoted S aureus
attachment to each of the mentioned plasma or extracellu-
lar matrix proteins individually adsorbed onto polymeric or
metallic surfaces. In contrast to S aureus, interaction of S
epidermidis and other CNS species with plasma and extra-
cellular matrix proteins has been characterized less well.17
Most in vitro studies of CNS attachment and colonization of
artificial surfaces were carried out in the absence of any pro-
tein coating and have focused on either slime production or
describing a capsular surface polysaccharide that promotes
adhesion to uncoated plastic.41,42
During the past 15 years, our group studied the role
of plasma or extracellular matrix proteins, in particular,
fibronectin, fibrinogen, or fibrin, in promoting S aureus
(and to some extent S epidermidis) adhesion to implanted
or inserted foreign materials.25 For in vivo studies, our
group used PMMA coverslips that were inserted in subcu-
taneously implanted tissue cages as described above.
Coverslips explanted 4 weeks after surgery are coated with
a complex network of matrix proteins and cellular ele-
ments: among them, fibronectin plays an important role in
promoting S aureus adhesion to those explanted cover-
slips.25 Adhesion of a protein A-defective strain of S aureus
to fibronectin deposited in vivo was inhibited by antibodies
to fibronectin.27
In a simplified in vitro assay, fibronectin22 strongly
promoted adhesion of all bacteremic isolates of S aureus
and S epidermidis, as opposed to fibrinogen and laminin,
which promoted S aureus, but rarely S epidermidis adhe-
sion.22 Thrombospondin,36 a glycoprotein present in
alpha-granules of platelets, also showed more binding
activity and promotion of bacterial attachment with clini-
cal isolates of S aureus than of S epidermidis. Activated
platelets bound to plastic surfaces also may promote
attachment to S aureus cells by interacting with fibrinogen
or fibrin.23
Further bacterial adhesion studies, relevant to clini-
cal situations of orthopedic infections of implanted metallic
devices and performed in collaboration with the Clinique
d’Orthopédie (University Hospital, Geneva, Switzerland)
also demonstrated that fibronectin was an important deter-
minant of S aureus and S epidermidis adhesion to either
stainless steel, pure titanium, or titanium-aluminum-
niobium–alloy coverslips.43 Bacterial adhesion to each cat-
egory of metallic surfaces coated in vitro with fibronectin
and to coverslips explanted from the subcutaneous space of
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guinea pigs was promoted strongly over albumin-coated
controls and was sensitive to inhibition by antifibronectin
antibodies.43
The clinical relevance of our experimental observa-
tions also was evaluated on a large number of peripheral
or central intravenous cannulas removed from hospital-
ized patients.27 Compared to uninserted catheters, which
allowed only minimal adhesion, previously inserted
catheters promoted significant adhesion of staphylococcal
isolates.27 To define the respective contribution of fib-
rinogen or fibrin and fibronectin in promoting S aureus
adhesion to central venous catheters, the amount, chemi-
cal integrity, and biologic activity of these proteins
adsorbed on intravenous lines inserted in hospitalized
patients were studied prospectively.44 Polyurethane
catheters promoted a significantly lower adhesion of S
aureus than polyvinyl chloride or Hickman cannulas and
contained the lowest amount of immunologically assayed
fibronectin, but not of fibrinogen or fibrin.44 Fibrinogen
showed an extensive loss of adhesion-promoting activity
on inserted cannulas, which was related to its proteolytic
breakdown, as detected by SDS-PAGE and immunoblots
with antifibrinogen antibodies25 and confirmed by in vitro
studies with purified protein fragments.44 In contrast,
either intact or fragmented fibronectin, although present
in much lower amounts than fibrinogen or fibrin, could
actively promote S aureus adhesion onto intravenous
catheters.44
MOLECULAR AND FUNCTIONAL
CHARACTERIZATION OF S AUREUS
ADHESINS
Significant progress recently was made in the molec-
ular identification, cloning, and sequencing of bacterial
genes coding for bacterial adhesins.17-20 These molecular
studies allowed structural and functional characterization
of the genes for a collagen adhesin29,30,45 and two distinct
but related fibronectin-binding proteins (FBP).46,47
Putative adhesins of fibrinogen, whose molecular structure
was related closely to that of staphylococcal coagulase, also
were described.48,49
To either identify novel bacterial adhesins, such as
the fibrinogen-binding protein (also called clumping factor,
see below), or to confirm the functional significance of
already described adhesins, a combined molecular and
functional approach was necessary. These studies were
promoted by the production of site-specific mutants of S
aureus specifically defective in adhesion to a single host
protein such as fibrinogen24 or fibronectin.50,51 Some of
these mutants were instrumental in allowing the cloning
and sequencing of a structural gene coding for a major fib-
rinogen adhesin.24 Other mutants defective for the pro-
duction of fibronectin adhesins demonstrated their role in
bacterial attachment to the host protein.
In addition, the function of adhesin(s)-defective
mutants could be restored by complementation with func-
tional genes located either on multicopy plasmids or inte-
grated into the bacterial chromosome.24,51 Some of these
restored mutants were useful for identification of host pro-
teins specifically contributing to bacterial attachment in
vivo.52
Fibrinogen-Binding Protein (Clumping Factor)
This recently discovered 92 kDa surface protein24
now is considered the major fibrinogen adhesin and medi-
ator of S aureus clumping.17,20,24,53 This discovery was
prompted by the isolation of four transposon-generated
mutants of S aureus strain Newman, which were defective
in the fibrinogen receptor (clumping factor) and mapped in
the same locus (clfA). All the mutants failed to form clumps
in soluble fibrinogen and lost attachment to PMMA cover-
slips coated in vitro with fibrinogen.24 The transposon-
generated mutants defective in fibrinogen binding were
very helpful for the cloning of the wild-type clumping factor
locus (clfA).24 The clfA gene is predicted to encode a cell
surface-associated fibrinogen-binding protein of 896
residues with a predicted molecular mass of 92 kDa
(Figure 1). The clfA protein has in its C-terminal region
features found in many cell surface-associated proteins in
gram-positive bacteria, namely an LPXTG motif, a
hydrophobic putative transmembrane domain and posi-
tively charged residues at the extreme C-terminus
(Figure 1).17,20
A single copy of the clfA gene, when introduced into
the chromosome of the mutant strains, fully complemented
the clumping deficiency of these strains and restored the
ability of these mutants to adhere to fibrinogen-coated
PMMA. In addition, the cloned clfA gene introduced on a
shuttle plasmid into a weakly fibrinogen-adherent strain of
S aureus transformed it into a strain of strong affinity for
surface-bound fibrinogen.24
The 520-residue N-terminal region A contains the fib-
rinogen-binding domain.54 Studies with recombinant trun-
cated derivatives of region A localized the fibrinogen-bind-
ing domain to a 218-residue segment (residues 332-550).
One truncate (220-550) retained the ability to bind fibrino-
gen, to block the attachment of bacteria to solid phase fib-
rinogen (Figure 2), and to prevent bacterial clumping in a
solution of fibrinogen.54 Antibodies raised against truncate
220-550 strongly inhibited both bacterial adhesion to fib-
rinogen-coated surfaces (Figure 2) and cell clumping. All
the smaller truncates lost the ability to interact with fib-
rinogen. One truncate (332-550) neutralized the ability of
polyclonal antibodies raised against truncate 220-550 to
block bacterial binding to fibrinogen. Antibodies raised
against the smaller protein also blocked bacterial interac-
tions with fibrinogen. This suggests that the ligand-binding
domain is located between residues 330-550 and that
residues 220-330 are required to promote correct folding of
the fibrinogen-binding domain. 
ClfA contains an unusual 308-residue region com-
prising 154 mainly Ser-Asp dipeptide repeats. A recombi-
nant protein comprising region R did not bind fibrinogen
and failed to block bacterial attachment to fibrinogen-coated
surfaces,54 and antiserum raised against region R did not
block bacterial attachment to fibrinogen-coated surfaces
(Figure 2). A deletion mutant lacking region R failed to
bind fibrinogen, suggesting that the function of this region
is to display the ligand-binding domain region A correctly
on the cell surface (O.M. Hartford, PhD, unpublished data,
August 1995).
To evaluate the in vivo contribution of fibrinogen or
fibrin to S aureus attachment during brief exposure of
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intravascular devices to flowing blood, we tested the clfA-
defective mutants or their complemented derivatives in an
ex vivo canine arteriovenous shunt model.52 After expo-
sure of polymer tubings to circulating canine blood for 5
to 60 minutes, segments of blood-exposed tubings were
tested for promotion of bacterial adhesion. S aureus
mutants lacking the fibrinogen adhesin were more defec-
tive in attachment to the blood-exposed tubings than
those lacking the fibronectin adhesin(s), compared to
their respective parental strains.52 In contrast, a highly
adhesive derivative strain of S aureus 8325-4, produced by
complementation with the plasmid pCF4 expressing mul-
tiple copies of the clfA gene, exhibited a strong increase
over the parental strain in bacterial adhesion to blood-
exposed tubing segments.52 These findings indicate that
fibrinogen and fibrin are the most active components for
initially promoting in vivo adhesion of S aureus, whereas
fibronectin and fibronectin proteolytic fragment are more
active in central venous catheters inserted for >24
hours.44
In a collaborative work with Philippe Moreillon, MD
(Infectious Diseases, University Hospital, Lausanne,
Switzerland), the contribution of the clfA protein to the initial
attachment and virulence of S aureus recently was evaluated
in a rat model of endocarditis.55 In this animal model of
endocarditis with catheter-induced aortic vegetations, the
virulence of various single or combined clfA- and coagulase-
defective mutants was tested. A significant reduction in the
ability of the clfA-defective mutant of S aureus to colonize
rat valves was observed. In contrast, the coagulase-defec-
tive mutant showed no significant difference with the
parental strain. Thus, the clumping factor also may con-
tribute to S aureus attachment to damaged heart valves
leading to bacterial endocarditis.55
Fibronectin-binding proteins. Molecular analysis of
the genetic locus encoding fibronectin-binding surface
component(s) of the laboratory strain 8325-4 of S aureus
revealed two related genes, called fnbA and fnbB, located
682 base pairs apart.19,46,47,56 Both fnb genes cloned in
Escherichia coli could express functional FBPs, called
FnBPA and FnBPB.18,19,46,47
Closely related ligand-binding domains have been
identified in both FnBPs using truncated protein fragments
and synthetic peptides in binding and inhibition studies.
This common binding domain is composed of a 38-amino-
acid unit that is repeated three times and partially a fourth,
which is called the D-repeat unit or D1-D417,19,56 (Figure
3). The functional role of the D-repeat region has been con-
firmed by blocking studies with recombinant and synthetic
peptides, which produce a very strong dose-dependent
inhibition of S aureus binding to either fluid-phase or solid-
phase fibronectin.19,56-59 These peptides exhibit a
stronger blocking activity than that of any polyclonal anti-
bodies thus far developed against the fibronectin
adhesins.60
To evaluate the role of each of the fibronectin
adhesins in vitro and in vivo, mutants of strain 8325-4 defec-
tive in the production of FnBPA, FnBPB, or both proteins
were produced by inserting DNA fragments encoding
antibiotic resistance into the fnb genes (a tetracycline resis-
tance marker into fnbA and an erythromycin resistance
marker into fnbB).51 Adhesion properties of either fnbA or
fnbB single mutants were not altered markedly compared to
those of the parental strain.51 In contrast, the double
fnbAfnbB mutant was completely defective for attachment to
either PMMA coverslips coated in vitro with fibronectin or
to coverslips explanted from the subcutaneous space of
guinea pigs.51 The parallelism between in vitro and in vivo
observations indicate an important role for FBPs in staphy-
lococcal attachment, colonization, and infection of biomate-
rial implants.
Another category of bacterial mutants defective in
FnBP production was generated by Kuypers and Proctor in
strain 879R4S of S aureus by transposon insertion.50 One
fibronectin-adhesin-defective mutant showed a markedly
reduced ability to adhere to traumatized heart valves and to
induce bacterial endocarditis in rats.50 A recently discov-
ered characteristic of the parental and mutant strains of S
aureus 879R4S is that it contains a single fnb gene closely
related to the fnbA of strain 8325-4.61 Recent molecular
studies of the fibronectin-adhesin-defective mutant strain
879R4S/1536 and its spectinomycin-derivative R4SSp/1536
FIGURE 2. (A) Schematic diagram showing the location of the clfA
fragments and the amino-acid numbers represented. (B) Inhibition
of Staphylococcus aureus adhesion to fibrinogen-coated poly-
methylmethacrylate (PMMA) coverslips by lysates containing clfA
truncates. (C) Inhibition of S aureus adhesion to fibrinogen-coated
PMMA coverslips by immunoglobulins purified from anti-clfA sera
and preimmune sera. Modified from reference 54 with permission
from Molecular Microbiology (1995;16:895-906).
FIGURE 1. Schematic drawing showing the domain organization of
Staphylococcus aureus fibrinogen-binding clfA protein. S, signal
sequence; A, nonrepeat domain; R, repeat domain; W, wall region;
M, membrane-spanning domain; +, positively charged residues.
The black box indicates the fibrinogen-binding region.
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demonstrated that the Tn918 transposon was inserted
between the promoter and coding sequence of the single
fnb gene,61 thus leading to its decreased expression.61
The mutant strain 879R4S/1536 showed interesting
adhesion defects in a novel animal model of orthopedic col-
onization developed in the orthopedic clinic of our hospi-
tal.62 In this model, which mimics conditions of internal fix-
ation devices, titanium miniplates were fixed onto the iliac
bones of guinea pigs or implanted into their subcutaneous
space as controls for a period of 5 to 6 weeks. A significant
reduction in adhesion of the fibronectin adhesin-defective
mutant compared to its isogenic parent occurred on the
metallic plates explanted from either the subcutaneous
space or the iliac bone. These data suggest that fibronectin
also may be present on bone-implanted metallic devices
and promote attachment of S aureus to their surface.62
STRATEGIES FOR DECREASING HOST
BACTERIA INTERACTIONS ON
FOREIGN BODIES
The combined development of molecular techniques
and experimental models of bacterial adhesion should help
to elucidate some of the most important clinically and epi-
demiologically relevant mechanisms of S aureus attach-
ment to major categories of biomaterial implants or
indwelling devices.
The ligand-binding domains of both fibronectin and
fibrinogen adhesins have been identified using truncated
protein fragments and synthetic peptides in binding and
inhibition studies. The binding domain of both fibronectin
adhesins is the D-repeat unit or D1-D4 (Figure 3).17,19,56
Synthetic peptides based on this fibronectin-binding
domain exhibit a stronger blocking activity on S aureus
binding to fibronectin19,56-59 than any polyclonal antibod-
ies thus far developed against the fibronectin adhesins.60
In contrast, polyclonal antibodies raised against the fibrino-
gen-binding domain of the clfA protein, which is located
within a 218-residue segment of its amino-terminal region
A (Figure 2), have shown a more potent activity against
bacterial clumping and adhesion to fibrinogen-coated poly-
meric surfaces than truncated peptides encompassing the
ligand-binding domain of clfA.54
The important advances in the molecular characteri-
zation of the fibrinogen-binding protein clfA24,54 and of
both FBPs A and B46,47,56 in S aureus, and the functional
demonstration24,51,52,54 that they contribute to attach-
ment to the purified host proteins, offer interesting per-
spectives for the development of a novel category of specif-
ic antiadhesive agents.17,56 Such agents would offer a use-
ful alternative to antibiotic prophylaxis in circumventing
the emergence of multiple resistance determinants in noso-
comial strains of staphylococci.
In addition to the fluid-phase specific antiadhesive
agents mentioned above, surface-bound molecules chang-
ing the chemical or physical properties of indwelling
devices also should be evaluated carefully. We recently
have described the impact of a surface coating procedure
on the physical and biological properties of a polyurethane
catheter.63 Coating of this polyurethane catheter with a
hydrogel based on cross-linked polyvinyl pyrrolidone led to
a dramatic increase in its surface smoothness and
hydrophilic properties.63 The hydrophilic polyurethane
catheter showed a strong reduction in the in vitro adsorp-
tion of either fibrinogen or fibronectin, leading to a propor-
tional reduction in protein-mediated adhesion of either S
aureus or S epidermidis.63
In conclusion, the combined development of specific
fluid-phase antiadhesive agents and improved surface treat-
ments of indwelling devices may lead to a significant reduc-
tion in bacterial colonization of the foreign bodies. Further
studies are needed to evaluate the clinical significance of
these in vitro observations. 
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Bartonella quintana first was
identified as an important human
pathogen during World War I, when it
caused epidemics of louse-borne
trench fever that affected an estimat-
ed 1 million troops in Europe. B quin-
tana infections rarely were recog-
nized from the end of the war until the
1980s, when the organism re-
emerged as an opportunistic
pathogen among HIV-infected per-
sons.
B quintana has emerged among
homeless persons in North America
and Europe. In 1993, the organism
first was isolated from the blood spec-
imens of 10 patients at a single hospi-
tal in Seattle, Washington, within a 6-
month period. These patients had ill-
nesses characterized by fever and
persistent bacteremia. Endocarditis
developed in two patients, one of
whom required a heart valve replace-
ment. All 10 patients had chronic alco-
holism, eight were homeless, and the
six who were tested for HIV were HIV
negative. These six were the first
cases of invasive B quintana infection
among HIV-negative persons report-
ed in the United States.
As a follow up to this Seattle out-
break, Dr. Lisa Jackson and Dr. David
Spach, from the University of
Washington in Seattle, conducted a
seroprevalence study of anti-
Bartonella antibodies among 192
patients at a community clinic in the
“skid row” section of Seattle, which
serves a primarily homeless and indi-
gent population. B quintana IgG titers
>64 were detected among 39 (20%) of
the 192 clinic patients.
The researchers note that multi-
ple factors likely have contributed to
the emergence of B quintana among
the homeless, including those related
to disease transmission, host suscep-
tibility, and ability to detect the organ-
isms. For example, transmission of B
quintana from human to human by
the body louse has been documented
experimentally. 
As with other emerging infec-
tious diseases, further efforts to iden-
tify, evaluate, and control these infec-
tions will require coordinated effort
of clinicians, microbiologists, and
public health officials.
FROM: Jackson LA, Spach DH.
Emergence of Bartonella quintana
infection among homeless persons.
Emerg Infect 1996;2(2):141-143.
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